Early Complete Response as Validated Surrogate Marker in Extranodal Marginal Zone Lymphoma Systemic Therapy. Bommier C, Zucca E, Chevret S, Conconi A, et al. Blood 2023 Oct 6:blood.2023020984. doi: 10.1182/blood.2023020984.

Read + Share

Amedeo Smart

Independent Medical Education

Bommier C, Zucca E, Chevret S, Conconi A, et al. Early Complete Response as Validated Surrogate Marker in Extranodal Marginal Zone Lymphoma Systemic Therapy. Blood 2023 Oct 6:blood.2023020984. doi: 10.1182/blood.2023020984.
PMID: 37801707